Literature DB >> 18174194

ALOX5 variants associated with susceptibility to human pulmonary tuberculosis.

Florian Herb1, Thorsten Thye, Stefan Niemann, Edmund N L Browne, Margaret A Chinbuah, John Gyapong, Ivy Osei, Ellis Owusu-Dabo, Oliver Werz, Sabine Rüsch-Gerdes, Rolf D Horstmann, Christian G Meyer.   

Abstract

The 5-lipoxygenase (ALOX5)-derived lipid mediators leukotrienes and lipoxins have regulatory functions in inflammation by modulating activities of immune cells and cytokine production. Recently, it was shown in ALOX5-/- mice that host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase (5-LO). ALOX5 polymorphisms were genotyped in 1916 sputum-positive patients with pulmonary tuberculosis (TB) from Ghana and in 2269 exposed, apparently healthy controls. Polymorphisms of a variable number of tandem repeats (VNTR) of the ALOX5 promoter and of the exonic non-synonymous variant g.760G>A were analysed by fragment length determination and fluorescence resonance energy transfer, respectively, and DNA sequencing. Mycobacterial lineages of >1400 isolates were differentiated biochemically and genetically. Carriers of one variant (n repeats not equal 5) and one wild-type VNTR allele (n = 5) or of the exonic allele g.760A had a higher risk of TB [P(corrected) = 0.026, odds ratio (OR) 1.19 (95% CI 1.04-1.37) and P(corrected) = 0.026, OR 1.21 (95% CI 1.04-1.41), respectively]. The association of the exonic variant was stronger in infections caused by the mycobacterial lineage M. africanum West-African 2 [P(corrected) = 0.024, OR 1.70; (95% CI 1.2-2.6)]. Determination of haplotypes revealed the strongest associaton with TB for the 'non-5/760A' haplotype compared with the 'non-5/760G' haplotype (P = 0.003, OR 1.50). Our observation of an association of ALOX5 variants with susceptibility to TB contributes evidence of the importance of 5-LO products to the regulation of immune responses to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174194     DOI: 10.1093/hmg/ddm378

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

1.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 2.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.

Authors:  Cesar Boggiano; Katrin Eichelberg; Lakshmi Ramachandra; Jaqueline Shea; Lalita Ramakrishnan; Samuel Behar; Joel D Ernst; Steven A Porcelli; Markus Maeurer; Hardy Kornfeld
Journal:  Vaccine       Date:  2017-05-02       Impact factor: 3.641

4.  Association of Sp1 tandem repeat polymorphism of ALOX5 with coronary artery disease in Indian subjects.

Authors:  Seema P Todur; Tester F Ashavaid
Journal:  Clin Transl Sci       Date:  2012-03-06       Impact factor: 4.689

5.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

6.  Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair.

Authors:  Maziar Divangahi; Minjian Chen; Huixian Gan; Danielle Desjardins; Tyler T Hickman; David M Lee; Sarah Fortune; Samuel M Behar; Heinz G Remold
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

7.  Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains.

Authors:  Christopher D Intemann; Thorsten Thye; Stefan Niemann; Edmund N L Browne; Margaret Amanua Chinbuah; Anthony Enimil; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Susanne Helm; Sabine Rüsch-Gerdes; Rolf D Horstmann; Christian G Meyer
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

8.  Strain-specific differences in the genetic control of two closely related mycobacteria.

Authors:  Tania Di Pietrantonio; Carmen Hernandez; Manon Girard; Annie Verville; Marianna Orlova; Adam Belley; Marcel A Behr; J Concepción Loredo-Osti; Erwin Schurr
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

9.  ALOX5 is associated with tuberculosis in a subset of the pediatric population of North China.

Authors:  Chen Shen; Xi-Rong Wu; Bin-Bin Wang; Lin Sun; Wei-Wei Jiao; Jing Wang; Wei-Xing Feng; Jing Xiao; Qing Miao; Fang Liu; Qing-Qin Yin; Xu Ma; A-Dong Shen
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

10.  IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB.

Authors:  Thorsten Thye; Edmund N Browne; Margaret A Chinbuah; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Norbert W Brattig; Stefan Niemann; Sabine Rüsch-Gerdes; Rolf D Horstmann; Christian G Meyer
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.